471 results on '"Onozawa, Y."'
Search Results
2. P-95 Bevacizumab, irinotecan and biweekly trifluridine/tipiracil for pretreated metastatic colorectal cancer: MODURATE, a phase Ib study
3. An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors
4. Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer
5. Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
6. Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution
7. SAFETY AND EFFICACY OF PROTON-BEAM RADIATION THERAPY FOR PATIENTS WITH LOCALLY RECURRENT RECTAL CANCER
8. EFFICACY AND SAFETY OF CHEMORADIOTHERAPY FOR PATIENTS WITH LOCOREGIONAL LYMPH NODE RECURRENCE OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA
9. IS ADJUVANT CHEMORADIOTHERAPY NECESSARY FOR HIGH-RISK OROPHARYNGEAL CANCER AFTER SURGERY?
10. CORRELATION BETWEEN THE EFFECTS OF FIRST-LINE CHEMOTHERAPY AND SURVIVAL TIME FROM SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
11. P-69 Efficacy and safety of S-1 following gemcitabine with cisplatin for biliary tract cancer
12. Incidence and influence of GB virus C and hepatitis C virus infection in patients undergoing bone marrow transplantation
13. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution
14. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation
15. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer
16. Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma
17. Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients
18. Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantation
19. Risk of Ischemic Heart Disease in Patients After Conccurent Chemoradiotherapy for Lung and Esophageal Cancer: A Case-Control Study
20. Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-gamma and tumour necrosis factor-alpha in patients with myelodysplastic syndromes
21. Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1)
22. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
23. Preventive effect of nutrition support on peroneal neuropathy in cancer patients
24. Clinical and immunological investigations in cryptogenic new-onset refractory status epilepticus (Norse)
25. Hole path concept for low switching loss and low EMI noise with high IE-effect
26. 218TiP A phase Ib study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplation (MODURATE)
27. Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
28. 61. Evaluation of the regional lymph node for cervical esophageal squamous cell carcinoma: Proposed selection for improved survival stratification
29. Trench shielded gate concept for improved switching performance with the low miller capacitance
30. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma
31. 165P Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
32. 1111P - Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
33. 1112P - Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1)
34. SUN-PP136: Changes in Body Weight and Body Mass Index After Esophagectomy
35. The compact and high power density 7th generation IGBT module
36. The advanced 7th generation IGBT module for high power density technology
37. Ultra low miller capacitance trench-gate IGBT with the split gate structure
38. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
39. Clinicopathological Features and Outcomes of Gastric Cancer Patients with Pulmonary Lymphangitis Carcinomatosa
40. The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury
41. Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
42. Cisplatin/5-FU 100/1000 in Japanese Patients With Recurrent/Metastatic SCCHN
43. Outcome of Anti-Egfr Antibody Therapy in Metastatic Colorectal Cancer with Low-Frequency Kras Mutations
44. Efficacy and Safety of Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer
45. The compact and high power density 7th generation IGBT module.
46. 668P - Risk factors for esophageal fistula in esophageal squamous cell carcinoma invading adjacent organs (T4b) treated with definitive chemoradiotherapy
47. Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
48. Safety and Efficacy of 5FU–LV (FL Therapy) as First-Line Chemotherapy in Patients of Advanced Gastric Cancer with Severe Ascites or Inadequate Oral Intake
49. Phase II Trial of Chemoradiotherapy Concurrent with S-1 Plus Cisplatin in Patients with Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Results of the Japan Clinical Oncology Group Study, JCOG 0706
50. S-1 Monotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck after Progression on Platinum-Based Chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.